SynthesisThe pharmacogenomics journal2019

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Luz M Canet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.